Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/2003
06/19/2003WO2002034899A3 Tec kinase assay
06/19/2003WO2002030979A3 Polypeptides homologous to thymosin, ephrin a receptors, and fibromodulin, and polynucleotides encoding same
06/19/2003WO2002029058A3 Human proteins, polynucleotides encoding them and methods of using the same
06/19/2003WO2002026815A3 Identification of neuroblastoma tumor suppressor genes
06/19/2003WO2002020801A3 26199, 33530, 33949, 47148, 50226, and 58764, human transferase family members and uses therefor
06/19/2003WO2002016648A3 Methods for external controls for nucleic acid amplification
06/19/2003WO2002012343A3 Proteins and nucleic acids encoding g-protein coupled receptors
06/19/2003WO2002004664A3 Genes comprising coding mononucleotide microsatellites or dinucleotide microsatellites that can be isolated from tumour cells
06/19/2003WO2002004514A3 Compositions and methods for the therapy and diagnosis of lung cancer
06/19/2003WO2002003849A3 Microarray method of genotyping multiple samples at multiple loci
06/19/2003WO2002000842A3 Methods for isolating centromere dna
06/19/2003WO2001096389A3 Compositions and methods for the therapy and diagnosis of colon cancer
06/19/2003WO2001015676A9 Compositions and methods for modulating hdl cholesterol and triglyceride levels
06/19/2003WO2001008635A3 Calcium channel transport polynucleotides, polypeptides, and antibodies
06/19/2003US20030115641 Transformation of plants by electroporation of cultured explants
06/19/2003US20030115640 Genetically engineered duckweed
06/19/2003US20030115639 Expressed sequences of arabidopsis thaliana
06/19/2003US20030115638 Plants having increased amino acids content and methods for producing the same
06/19/2003US20030115637 Embryo sac-specific genes
06/19/2003US20030115636 DNA encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5A, transgenic plants and a method for controlling senescence programmed and cell death in plants
06/19/2003US20030115635 Controlling gene expression, apoptosis in plants
06/19/2003US20030115634 Dna sequence from Plasmodium; detection of herbicides, viricides, bactericides, fungicides
06/19/2003US20030115633 Transgenic plant; delay, control ripening; polypeptides;
06/19/2003US20030115632 Diacylglycerol acyl transferase proteins
06/19/2003US20030115631 Transgenic plants; prevent diseases
06/19/2003US20030115630 Insecticide for transgenic corn; genetic engineering
06/19/2003US20030115628 Nucleotide sequences coding for polypeptides endowed with a larvicidal activity towards lepidoptera
06/19/2003US20030115627 Genetic engineering; isolated nucleic acid
06/19/2003US20030115626 Genetic engineereed herbicide; controlling weeds
06/19/2003US20030115625 Enoyl-ACP reductases
06/19/2003US20030115623 Methods and compositions for producing donor cells, as well as tissues and organs comprising the same
06/19/2003US20030115621 Detection of central nervous system disorders using tau protein
06/19/2003US20030115619 Animal with reduced sensitivity to disease
06/19/2003US20030115618 Method of generating a transgenic livestock animal
06/19/2003US20030115616 Transgenic animal; urokinase plasminogen activator; viricides; detecting liver toxicity
06/19/2003US20030114660 Hybrid oligonucleotide
06/19/2003US20030114659 Single domain ligands, receptors comprising said ligands, methods for their production, and use of said ligands and receptors
06/19/2003US20030114658 Vascular endothelial growth factor D (VEGF-D) antibodies and vectors, and methods of use
06/19/2003US20030114657 Central nervous system disorders; brain disorders
06/19/2003US20030114656 Phosphoserine phosphatase gene of coryneform bacteria
06/19/2003US20030114655 Phytochelatin synthase
06/19/2003US20030114654 Antithrombin nucleotides and proteins from horn fly
06/19/2003US20030114651 Methods and reagents for preserving RNA in cell and tissue samples
06/19/2003US20030114646 Human cystatin F
06/19/2003US20030114413 A nucleotide sequence coding for a protein comprising a positive function in a regulatory pathway, e.g Drosophila Legless (Lgs) protein; component of the Wnt/Wingless (Wnt/Wg) signal transduction; anticarcinogenic and -tumor agents
06/19/2003US20030114412 Antisense modulation of RECQL5 expression
06/19/2003US20030114411 Removing an aberrant native intron by splicing using a gene transfer vector expressing a heterologous RNA joined to an antisense oligonucleotide which blocks a second set of splice elements; mutants; gene therapy; genetic disorders
06/19/2003US20030114410 Angiogenesis inhibition by administering into the tissue a molecule ,e.g., novel platelet factor 4 binding protein, to deactivate a lysyl oxidase; antimetastasis, -carcinogenic and -tumor agents; suppression of fibrosis
06/19/2003US20030114409 Facilitation of RNA interference
06/19/2003US20030114407 Antisense modulation of G protein-coupled receptor ETBR-LP-2 expression
06/19/2003US20030114405 Administering a conjugate of a non-immunogenic valency platform molecule, e.g., biodegradable polymer or protein, and at least two double stranded DNA epitopes, e,g., DNA molecules, which bind to anti-DNA antibodies from the patient
06/19/2003US20030114404 Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes
06/19/2003US20030114402 Modulators of DNA cytosine-5 methyltransferase and methods for use thereof
06/19/2003US20030114401 Antisense modulation of Ship-1 expression
06/19/2003US20030114400 Oligonucleotide hybridizes with nucleic acid encoding phosphatidylinositol-4-phosphate 5-kinase, I alpha to inhibits gene expression; antiproliferative, -carcinogenic and -inflammatory agents
06/19/2003US20030114398 Monoclonal antiidiotype antibody 1A7 eliciting an anti-ganglioside GD2 response and overcomes immune tolerance; detecting an anti-GD2 antibody bound to a tumor cell; kits; melanoma, neuroblastoma, glioma, soft tissue sarcoma
06/19/2003US20030114385 Viral enzyme activated prototoxophores and use of same to treat viral infections
06/19/2003US20030114384 Methods and compositions for treating lesions of the respiratory epithelium
06/19/2003US20030114382 Angiogenesis inhibition
06/19/2003US20030114375 Method for treating cystic fibrosis
06/19/2003US20030114371 Hybridizable nucleic acid, cDNA sequence, recombinant vector and host cells, isolated antibody; a neural disorder related to drug addiction, immune disorder, transplant rejection, cell proliferative disorder, cancer treatment; drug screening
06/19/2003US20030114370 Nucleic acid molecules encoding endostatin protein and peptide fragments thereof
06/19/2003US20030114369 HIV-specific CTL inducing peptides and medicaments for preventing or treating AIDS comprising the peptides
06/19/2003US20030114368 Immunotoxins directed against malignant cells
06/19/2003US20030114357 Antidiabetic agents
06/19/2003US20030114330 BGL5 beta-glucosidase and nucleic acids encoding the same
06/19/2003US20030113926 Centrifugal spectrometer
06/19/2003US20030113921 Nucleic acid sequences capable of improving homologous recombination in plants and plant plastids
06/19/2003US20030113920 Transducting, dividing cells; gene expression; gene therapy
06/19/2003US20030113919 Anticancer agents
06/19/2003US20030113917 Methods for delivering nucleic acid molecules into cells and assessment thereof
06/19/2003US20030113914 Antisense modulation of CD81 expression
06/19/2003US20030113909 G protein coupled receptor protein, production and use thereof
06/19/2003US20030113900 Incubation, culture product, drying, stabilization; storage stability; freeze drying in presence of trehalose
06/19/2003US20030113898 Methods for producing high titre vectors and compositions used in such methods
06/19/2003US20030113895 Proteases from gram-positive organisms
06/19/2003US20030113894 Therapy for kidney diseases; cardiovascular disorders
06/19/2003US20030113893 D-aminoacylases, method for producing the same, and method for producing D-amino acids using the same
06/19/2003US20030113892 Isolated polypeptides and compositions from the venom of P. transvaalicus and methods of use
06/19/2003US20030113887 Use of restriction endonuclease I-SceI for mapping eukaryotic genomes and for in vivo site directed genetic recombination
06/19/2003US20030113884 Genetic engineering; using enzyme; isolated nucleic acids
06/19/2003US20030113883 Corynebacterium, Brevibacterium; culture product
06/19/2003US20030113880 DNA for encoding D-hydantoin hydrolases, DNA for encoding N-carbamyl-D-amino acid hydrolases, recombinant DNA containing the genes, cells transformed with the recombinant DNA, methods for producing proteins utilizing the transformed cells and methods for producing D-amino acids
06/19/2003US20030113878 Novel bacterial strains, methods of preparing the same and use thereof in fermentation processes for L-lysine production
06/19/2003US20030113875 Creating multiple RNA copies starting from messenger RNA; gene expression analysis; aging resistance
06/19/2003US20030113874 Macrolide antibiotic; microbiocides
06/19/2003US20030113873 Screening modulators of G-protein coupled binding proteins; analgesics; muscle-relaxants; cognition activators; learning enhancement
06/19/2003US20030113871 Glycoprotein hormones; human chorionic gonadotropin; carboxy terminal peptides (ctp); increaseing half life of polypeptides; antipernicious anemia drugs
06/19/2003US20030113870 Polypeptides homologous to VEGF and BMP1
06/19/2003US20030113869 Human FGF gene and gene expression products
06/19/2003US20030113868 Human metabotropic glutamate receptor subtype mGluR7b
06/19/2003US20030113867 Muscle receptor proteins; transport proteins; antitumor agents; antiinflammatory agents; antidiabetic agents; modulation of muscle contraction
06/19/2003US20030113844 Delayed rectifier potassium channel subunit
06/19/2003US20030113843 For stimulating release of tumor necrosis factor, and/or cell proliferation/differentiation of chrondrocytes by contacting blood with polypeptides; antiinflammatory agents; anticarcingenic agents; antitumor agents; cancer diagnosis
06/19/2003US20030113840 25 human secreted proteins
06/19/2003US20030113839 Histamine H2 receptor and uses
06/19/2003US20030113837 Tyrosine recombinase for genetic engineering
06/19/2003US20030113831 Detecting modulators of cytokine activity; bronchodilator agents; antiarthritic agents; glucocorticoids; leukotriene antagonists; corticosteroids
06/19/2003US20030113816 Methods of assaying connective tissue growth factor
06/19/2003US20030113807 Discrimination between different cellular pathways and their use in the determination of the effect of agents on cell culture
1 ... 2492 2493 2494 2495 2496 2497 2498 2499 2500 2501 2502 2503 2504 2505 2506 2507 2508 2509 2510 2511 2512 ... 4023